SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS

被引：14
|
作者：
LABAYLE, D [1 ]
BOYER, J [1 ]
DROUHIN, F [1 ]
ZARKA, Y [1 ]
FISCHER, D [1 ]
机构：
[1] CHU ANGERS,SERV HEPATOGASTROENTEROL,ANGERS,FRANCE
来源：
LANCET | 1994年 / 343卷 / 8894期
关键词：
D O I：
10.1016/S0140-6736(94)91253-X
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：417 / 418
页数：2
相关论文
共 50 条
  • [21] SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS - INTERIM RESULTS OF A PROSPECTIVE-STUDY
    MULLER, A
    HURLIMANN, R
    MEYENBERGER, C
    STAUB, P
    KOBLER, E
    AMMANN, R
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1994, 124 (15) : 651 - 654
  • [22] Molecular analysis of sulindac-resistant adenomas in familial adenomatous polyposis
    Keller, JJ
    Offerhaus, GJA
    Drillenburg, P
    Caspers, E
    Musler, A
    Ristimäki, A
    Giardiello, FM
    [J]. CLINICAL CANCER RESEARCH, 2001, 7 (12) : 4000 - 4007
  • [23] Sulindac resistant adenomas in familial adenomatous polyposis patients: A molecular evaluation
    Keller, JJ
    Offerhaus, JA
    Drillenburg, P
    Caspers, E
    Musler, A
    Ristimaki, A
    Hylind, LM
    Romans, KE
    Giardiello, FM
    [J]. GASTROENTEROLOGY, 2001, 120 (05) : A300 - A300
  • [24] SULINDAC THERAPY FOR FAMILIAL ADENOMATOUS POLYPOSIS AFTER COLECTOMY AND ILEORECTAL ANASTOMOSIS
    MAKELA, JT
    LAITINEN, S
    [J]. ANNALES CHIRURGIAE ET GYNAECOLOGIAE, 1994, 83 (03) : 265 - 267
  • [25] Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis
    Bowen, Charles M.
    Walter, Lewins
    Borras, Ester
    Wu, Wenhui
    Ozcan, Zuhal
    Chang, Kyle
    Bommi, Prashant, V
    Taggart, Melissa W.
    Thirumurthi, Selvi
    Lynch, Patrick M.
    Reyes-Uribe, Laura
    Scheet, Paul A.
    Sinha, Krishna M.
    Vilar, Eduardo
    [J]. CANCER PREVENTION RESEARCH, 2021, 14 (09) : 851 - 862
  • [26] Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac
    Nugent, KP
    Spigelman, AD
    Phillips, RKS
    [J]. DISEASES OF THE COLON & RECTUM, 1996, 39 (06) : 659 - 662
  • [27] Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac
    Keller, JJ
    Offerhaus, GJA
    Polak, M
    Goodman, SN
    Zahurak, ML
    Hylind, LM
    Hamilton, SR
    Giardiello, FM
    [J]. GUT, 1999, 45 (06) : 822 - 828
  • [28] INHIBITION OF APOPTOSIS IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) AND ITS MODIFICATION BY SULINDAC
    PASRICHA, PJ
    BEDI, A
    RASHID, A
    HAMILTON, SR
    AKHTAR, AJ
    OCONNOR, K
    GIARDIELLO, FM
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A523 - A523
  • [29] Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis
    Winde, G
    Schmid, KW
    Brandt, B
    Muller, O
    Osswald, H
    [J]. DISEASES OF THE COLON & RECTUM, 1997, 40 (10) : 1156 - 1168
  • [30] REGRESSION OF ADENOMAS IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) IS ENHANCED IN THE PROXIMAL COLON BY SULINDAC
    HURLIMANN, R
    MULLER, A
    MEYENBERGER, C
    SCOTT, R
    AMMANN, R
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : A394 - A394
12345